Key result
A wearable device using ECG and BCG signals to estimate central aortic blood pressure correlated significantly with a cuff-based device (Pearson correlation 0.82 systolic, 0.78 diastolic; p<0.001).
Why the study?
Continuous and wearable central aortic blood pressure monitoring may improve hypertension management, but whether an ECG- and BCG-equipped wearable device can predict central aortic blood pressure needed experimental evaluation.
Does a wearable device equipped with ECG and BCG accurately estimate central aortic blood pressure compared to a cuff-based device in young healthy volunteers?
Cross-Sectional (n=10)
Does a wearable device equipped with ECG and BCG accurately estimate central aortic blood pressure compared to a cuff-based device in young healthy volunteers?
A wearable device utilizing ECG and BCG signals to extract pulse transit time can accurately estimate central aortic blood pressure during various hemodynamic interventions.
Answers are grounded in this paper and cite their sources.
Does not support routine CABP monitoring with wearables yet; leaves open further development for continuous hypertension assessment.
Evidence suggests that central aortic blood pressure (CABP) may provide a more accurate prognosis of cardiovascular events than peripheral pressure. The capability of monitoring CABP in a continuous, wearable, unobtrusive way might have a significant impact on hypertension management. The purpose of this study is to experimentally explore whether a wearable device equipped with an electrocardiogram (ECG) and ballistocardiogram (BCG) acquisition system could be used to predict CABP. This is based on state-of-the-art results on the relationship between transit time extracted from these signals and CABP. Ten young, healthy volunteers participated in the study where data-sets were acquired during three hemodynamic interventions, i.e., breath-holding, Valsalva maneuver, and cold pressor. Each data-set included ECG and BCG waveforms acquired by the wearable device and a CABP assessment from a cuff-based device. A total of nine PTT-based models (PBMs) derived from pulse transit time methodology were considered. Each PBM was tested with three alternative feature times extracted from the recorded waveforms PBMs were calibrated with data-sets acquired at baseline state, which were not considered for testing the PBM estimation performance. Four of the nine tested models presented a proper agreement in estimating CABP through the acquired signals, after the calibration procedure with baseline-state data. Results in one of these promising models are the following. Mean estimation error (95% confidence interval), systolic: 0 to 1.7 mmHg, diastolic: 0.4 to 2.3 mmHg, Pearson correlation: 0.82 systolic and 0.78 diastolic (p < 0.001). The proposed methodology may lead to continuous wearable BP monitoring.
No takes yet. Share an insight, caveat, or question.
Fierro et al. (2020) conducted a cross-sectional in Healthy volunteers (n=10). Wearable device equipped with ECG and BCG acquisition system vs. Cuff-based device was evaluated on Central aortic blood pressure (CABP) estimation accuracy (Pearson correlation: 0.82 systolic and 0.78 diastolic, 95% CI systolic error: 0 to 1.7 mmHg, diastolic error: 0.4 to 2.3 mmHg, p=<0.001). A wearable device using ECG and BCG signals to estimate central aortic blood pressure correlated significantly with a cuff-based device (Pearson correlation 0.82 systolic, 0.78 diastolic; p<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: